Hi Tokyo Jo
Could you please let me know who the author of that report "ecg" is? And secondly, perhaps you could assist with a reference to somewhere I could research the P factor the report refers to. I understand the observations about limitations of the value of the study given the low number of "events" of recurrence. But I do not understand the link between P factor and future Phase 3 trial.
regards
DF